Abiopharma

🔍 WIERENGA WENDELL (Director)

Company: Dermata Therapeutics, Inc. (DRMA)

Report Date: 2026-01-02

Detailed Transactions and Holdings:

• Acquired 2,500 shares of Stock Option (Right to Buy) at $2.18 per share (Derivative)
  Date: 2026-01-02 | Code: A | Expires: 2036-01-01 | equity_swap_involved: 0 | shares_owned_after: 2,500.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: The shares underlying the option will vest in a series of twelve (12) successive substantially equal monthly installments, with the first installment vesting on the one month anniversary of the grant date and continuing to vest monthly thereafter, subject to Reporting Person's continuous service through each such vesting date.